KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis

Abstract

HRMA was found to be a valid screening method for KRAS mutation detection. The KRAS mutation came forward as a negative predictive factor for OS in patients with rectal cancer and for DFS in stage II colon cancer patients.